Shinya Okuda
Astellas Pharma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shinya Okuda.
Bioorganic & Medicinal Chemistry Letters | 2008
Ayako Toda; Hidenori Ohki; Toshio Yamanaka; Kenji Murano; Shinya Okuda; Kohji Kawabata; Kazuo Hatano; Keiji Matsuda; Keiji Misumi; Kenji Itoh; Kenji Satoh; Satoshi Inoue
We describe herein the synthesis and biological evaluation of a series of novel cephalosporins with potent activity against Pseudomonas aeruginosa. Introduction of various amino groups to the 4-position of a 3-amino-2-methylpyrazole cephalosporin 3-side chain resulted in enhanced MIC values against multiple Pseudomonas aeruginosa strains and ultimately led to the discovery of FR264205 (15) with excellent anti-bacterial activity and weak convulsion effect by direct intracerebroventricular injection assay.
Bioorganic & Medicinal Chemistry | 2002
Hirofumi Yamamoto; Yoshiteru Eikyu; Shinya Okuda; Kohji Kawabata; Hisashi Takasugi; Hirokazu Tanaka; Satoru Matsumoto; Yoshimi Matsumoto; Shuichi Tawara
A series of 3-(4-pyrazolylmethylthio)cephalosporins with various C-7 side chains was designed, synthesized and evaluated for antibacterial activity and oral absorption in rats. Antibacterial activity against Haemophilus influenzae was markedly increased by the C-7 oxime moiety. Deamination at the 2 position of, or introduction of a substituent such as halogen or methyl to, the 5 position of the (Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino) moiety improved oral absorption. Among these compounds, FR192752 having a (Z)-2-(2-amino-5-chlorothiazol-4-yl)-2-hydroxyiminoacetamido moiety, showed potent antibacterial activity against both Gram-positive and Gram-negative bacteria including H.influenzae and penicillin G-resistant Streptococcus pneumoniae (PRSP). Further, it showed higher oral absorption than CFDN and FK041.
Bioorganic & Medicinal Chemistry | 1997
Hidenori Ohki; Kohji Kawabata; Yoshiko Inamoto; Shinya Okuda; Toshiaki Kamimura; Kazuo Sakane
The synthesis and in vitro antibacterial activity of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]cephalos porins bearing N-mono or dialkyl and carbamoyl aminopyrazolium, and five- or six-membered rings fused to the 3-aminopyrazolium methyl groups at the 3-position, are described. Aminopyrazolium methyl cephalosporins (23e, f, i), with fused saturated and unsaturated rings were especially effective against Staphylococcus strains compared to 3-amino-2-methylpyrazolium methyl cephalosporin (1). Among the cephalosporins prepared in this work, 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-(4,5, 6, 7-tetrahydro-1-pyrazolo[1,5-a]pyrimidinio)methyl-3-cephem-4-carbox ylate (23f) showed a good balance of antibacterial activity against both Gram-positive bacteria including Staphylococcus aureus and Gram-negative bacteria including P. aeruginosa. An imidazopyrazolium group at the 3-position in, for example, cephalosporin (23i) was particularly effective for improving antibacterial activity against MRSA.
Archive | 1994
Kohji Kawabata; Hirofumi Yamamoto; Yoshiteru Eikyu; Shinya Okuda; Hisashi Takasugi
Archive | 1994
Kazuo Sakane; Kohji Kawabata; Shinya Okuda
Bioorganic & Medicinal Chemistry | 2008
Kenji Murano; Toshio Yamanaka; Ayako Toda; Hidenori Ohki; Shinya Okuda; Kohji Kawabata; Kazuo Hatano; Shinobu Takeda; Hisashi Akamatsu; Kenji Itoh; Keiji Misumi; Satoshi Inoue; Tatsuya Takagi
The Journal of Antibiotics | 1993
Hidenori Ohki; Kohji Kawabata; Shinya Okuda; Toshiaki Kamimura; Kazuo Sakane
Archive | 2007
Toshio Yamanaka; Ayako Toda; Hidenori Ohki; Shinya Okuda; Kohji Kawabata; Kenji Murano; Kazuo Hatano; Shinobu Takeda; Toru Nakai; Masaru Oogaki; Satoshi Inoue; Keiji Misumi; Kenji Itoh
Archive | 1997
Yoshiki Yoshida; Shinya Okuda; Hiroshi Sasaki; Keiji Matsuda; Hisashi Takasugi
Archive | 1997
Kohji Kawabata; Shinya Okuda; Kohei Kishi; Yoshiteru Eikyu; Hisashi Takasugi